Sign Up for Alerts
Sign up to receive receive industry-specific emails from our legal team.
Sign Up for Alerts
We provide tailored, industry-specific legal updates to our clients and other friends of the firm.
Areas of Interest
June 27th, 2022
Quentin Tarantino Tries for an Early Court Win in ‘Pulp Fiction’ NFT Legal Battle
Blockchain Technology Co-Chair Jeremy S. Goldman is quoted in the article, “Quentin Tarantino Tries for an Early Court Win in ‘Pulp Fiction’ NFT Legal Battle” published by The Hollywood Reporter. The article discusses Miramax’s lawsuit against Quentin Tarantino over plans to release non-fungible tokens based on the movie Pulp Fiction. In a recent motion, Tarantino argues his NFTs are based on his copyrights to the screenplay and don't infringe on Miramax's copyrights to the movie. Jeremy is quoted saying, “Both sides have their reserved rights and both sides have the ability to use NFTs to exercise those rights — Miramax with regard to the movie and Tarantino with regard to the screenplay.”
In the case, Miramax is leaning on contract language that says it owns all media rights but NFTs aren’t traditionally considered media. Jeremy says, “NFTs are not a form of distribution or media — that’s the misunderstanding by Miramax.” He adds, “They view NFTs as a medium for distribution, part of how people view content. That’s not what it is. It’s just a record of ownership.”
Read the full article here.
Other Quoted
‘I have been hunted down by HR reps, lawyers, and comms people:’ Developers discuss the pain and prevalence of side work clauses
Wendy Stryker was quoted in a Game Developer article discussing "side work clauses," also known as "moonlighting clauses," in video game industry employment contracts. Read more.
July 30 2026
Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads
Jeffrey A. Greenbaum was quoted in the Regulatory Affairs Professionals Society (RAPS) article, "Experts: Ending Adequate Provision Would Shut Down Prescription Drug Ads." The article discusses the FDA's proposal to eliminate the "adequate provision" requirement in direct-to-consumer (DTC) prescription drug advertising, a change that experts say could effectively result in a de facto ban on prescription drug advertisements. Read more.
July 21 2026
What Cannes Lions Can Teach Us About Advertising’s Most Important Customer
Cannes Lions brought important conversations to the stage about advertising’s most important stakeholder: the public. Read more.
July 2 2026
